香港股市 已收市

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX 延遲價格。貨幣為 AUD。
加入追蹤清單
3.6300+0.1400 (+4.01%)
收市價: 04:10PM AEDT

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 3 9538 6777
https://www.clinicallabs.com.au

版塊Healthcare
行業Diagnostics & Research
全職員工5,400

高階主管

名稱標題支付行使價出生年份
Ms. Melinda McGrathCEO & Exec. Director1.81M
Mr. James DavisonChief Financial Officer936.09k
Mr. Anthony FriedliChief Operating Officer
Mr. Sean JacksonChief Information Officer
Mr. Joe GeranNational Marketing Director
Associate Prof. Tony LandgrenNational Medical Director & Chief Pathologist
Mr. Chris BrownlowChief Exec. Officer of New South Wales & Australian Capital Territory
Ms. Shae SeymourChief Exec. Officer of Western Australia
Mr. Eric SwaynChief Exec. Officer of South Australia & Northern Territory
Ms. Eleanor Padman B.A., FCISCompany Sec.
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 AUD。

描述

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

公司管治

截至 無 止,Australian Clinical Labs Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。